Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

Roel G.W. Verhaak(University of New Haven), Matthew Meyerson(Broad Institute), Robert C. Onofrio(Broad Institute), Sebastián Martín Gómez(Harvard University Press), Pablo Tamayo(Dana-Farber Cancer Institute), Diana Hubbard(Harvard University Press), Anna DeFazio(Peter MacCallum Cancer Centre), Scott L. Carter(Broad Institute), David D.L. Bowtell(The University of Melbourne), John N. Weinstein(The University of Texas MD Anderson Cancer Center), Joe W. Gray(University of Newcastle Australia), Nianxiang Zhang(The University of Texas MD Anderson Cancer Center), Douglas A. Levine(New York University), A Kahn(SRA International (United States)), Paul T. Spellman(Oregon Health & Science University), Chad J. Creighton(Baylor College of Medicine), Keren Levanon(Sheba Medical Center), Robert A. Soslow(Cleveland Clinic), Gordon Saksena, Kristian Cibulskis(Broad Institute), Rehan Akbani(The University of Texas MD Anderson Cancer Center), Sián Fereday(Peter MacCallum Cancer Centre), Stacey Gabriel(Broad Institute), Aleksandar D. Kostic(Joslin Diabetes Center), Ronny Drapkin(University of Pennsylvania), Hailei Zhang(Hebei University), Aviad Tsherniak(Broad Institute), Michael S. Lawrence(Broad Institute), Jill P. Mesirov(University of California San Diego), Carrie Sougnez(Broad Institute), David G. Huntsman(BC Cancer Agency), Martin Köbel(University of Calgary), Dariush Etemadmoghadam(Peter MacCallum Cancer Centre), Craig H. Mermel(California University of Pennsylvania), Yiqun Zhang(Baylor College of Medicine), Ji-Yeon Yang(The University of Texas MD Anderson Cancer Center), Michael J. Birrer(University of Arkansas Medical Center), Lynda Chin(American Productivity and Quality Center), Gad Getz(Broad Institute), Sekhar Duraisamy(Dana-Farber Cancer Institute), Katherine A. Hoadley(University of North Carolina at Chapel Hill)
Journal of Clinical Investigation
December 21, 2012
Cited by 591


Related Papers